Terumo cuts operating profit forecast 25.6% as Aortic recall brings ¥38bn asset-value risk
Terumo's Aortic recall costs about ¥3bn of adjusted operating profit, but about ¥38bn of asset-value risk, not yet final, drives a 25.6% cut to its reported operating profit forecast, now ¥119.0bn.